UK markets open in 7 hours 31 minutes

Galectin Therapeutics, Inc. (GALT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.5000-0.0100 (-0.28%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-0.16-0.16-0.66-1.59
Low estimate-0.16-0.16-0.66-1.59
High estimate-0.16-0.16-0.66-1.59
Year ago EPS-0.19-0.15-0.74-0.66
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. EstimateN/AN/AN/A36.32M
Low estimateN/AN/AN/A36.32M
High estimateN/AN/AN/A36.32M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.21-0.21-0.16-0.16
Actual EPS-0.19-0.15-0.24-0.16
Difference0.020.06-0.080
Surprise %9.50%28.60%-50.00%0.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.16-0.16-0.66-1.59
7 days ago-0.16-0.16-0.66-1.59
30 days ago-0.16-0.16-0.66-1.37
60 days ago-0.16-0.16-0.66-1.37
90 days ago-0.16-0.16-0.66-1.37
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesGALTIndustrySector(s)S&P 500
Current qtr.15.80%N/AN/AN/A
Next qtr.-6.70%N/AN/AN/A
Current year10.80%N/AN/AN/A
Next year-140.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A